03347 TIGERMED
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.72X | Oper Margin | 11.8% |
|---|---|---|---|
| LT Debt/Equity | 3.5% | Net Margin | 6.1% |
| Total Debt/Equity | 12.8% | Return on Equity | 2.0% |
| Price/Book | 1.89X | Return on Assets | 1.4% |
| (HKD 48.350) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 430.87 | 2,233.62 | 2,260.44 | 3,519.93 | 2,076.46 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -80.7 | -1.2 | -35.8 | +69.5 | +121.1 |
| Earnings Per Share (HKD) | 0.499 | 2.582 | 2.614 | 4.066 | 2.617 |
| Earnings Per Share Growth (%) | -80.7 | -1.2 | -35.7 | +55.4 | +100.0 |
| Dividend Per Share (HKD) | 0.325 | 0.624 | 0.616 | 0.580 | 0.362 |
| P/E* (X) | 96.85 | 18.72 | 18.50 | 11.89 | 18.48 |
| Yield (%) | 0.67 | 1.29 | 1.27 | 1.20 | 0.75 |
| Dividend Share (%) | 65.00 | 24.15 | 23.55 | 14.25 | 13.83 |
| Book NAV (HKD) | 25.524 | 26.618 | 25.226 | 25.495 | 21.973 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2025-03 | 2020-03 | Chg* (%) | 2019-03 |
| Cover Period (mths) | 3 | 3 | NA | 3 |
|---|---|---|---|---|
| Turnover | 1,564 | 654.971 | +138.8 | 604.984 |
| Operating Result | 143.927 | 214.778 | -33.0 | 188.727 |
| Associates | 0 | -2.823 | -100.0 | -13.496 |
| Profit Before Taxation | 143.625 | 288.695 | -50.3 | 228.484 |
| Taxation | 33.644 | 25.726 | +30.8 | 26.587 |
| Profit /( Loss) After Taxation | 109.981 | 262.969 | -58.2 | 201.897 |
| Minority Interests | -55.488 | -0.408 | +13,500.0 | 10.46 |
| Net Profit | 165.469 | 263.377 | -37.2 | 191.437 |
| Earnings Per Share () | 0.2038 | N/A | N/A | N/A |
| Announcement Date | 2025-04-28 | 2020-07-28 | NA | 2020-07-28 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
